NCT01126931UnknownNot Applicable
Pilot Trial With Wormwood to Improve Appetite in Cancer, Autoimmune Diseases, Depression and Old Age
University Hospital Freiburg1 site in 1 country300 target enrollmentStarted: February 2006Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Improvement in appetite
Study Overview
Brief Summary
Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer.
Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite
Detailed Description
Supplementation with wormwood in chronic disorders associated with reduced appetite.
Examples:
- Cancer
- Autoimmune diseases such as Crohns disease and IgA Nephropathy
- Old age
- Chronic stress and depression
Study Design
- Study Type
- Observational
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Appetite and weight loss
- •Chronic progressive disease
Exclusion Criteria
- •Life expectancy less than 3 months
Outcomes
Primary Outcomes
Improvement in appetite
Time Frame: 6-12 months
Secondary Outcomes
- Improvement in quality of life(12-24 months)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
A Clinical Study of De-Stress & Chill Gummies in Reducing StressStressAnxietyNCT06571071Herbolab India Pvt. Ltd.72
Not yet recruiting
Not Applicable
Clinical Study of De-Stress & Happy Gut Powder for Stress and Indigestion in Adults.StressIndigestionDyspepsiaNCT06568965Herbolab India Pvt. Ltd.81
Completed
Not Applicable
A Short-Term Appetite Suppression Trial Using Appethyl™: The PizzaOverweightObesityNCT01919814Pennington Biomedical Research Center60
Not yet recruiting
Phase 1
Herbal mouthwash for bleeding gums and plaque controlCTRI/2018/11/016395ational innovation Foundation
Completed
Phase 1
Effects of the D3 Antagonist GSK598809 on Food Reward and ReinforcementSubstance DependenceNCT01039454GlaxoSmithKline24